Lawmakers and regulators in Washington are starting to puzzle over how to regulate artificial intelligence in health care — and the AI industry thinks there’s a good chance they’ll mess it up.
Psyence Group Corporate Update | Psychedelic Invest
Psyence Group Inc. (CSE: PSYG / OTCQB: PSYGF) is pleased to provide the following corporate update on its strategic focus areas namely: Psyence Therapeutics and Psyence Production. The